SCHEMBL189440

SCHEMBL189440

Cc1ccccc1CN(Cc1ccccc1C)Cc1ccccc1C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.60
TAAR1 Q96RJ0 1/20 0.50
KMT2A Q03164 3/20 0.49
MEN1 O00255 1/20 0.49
ACHE P22303 2/20 0.45
TSHR P16473 2/20 0.45
BCHE P06276 1/20 0.45
CHRM2 P08172 1/20 0.42
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
NR1D1 P20393 1/20 0.40
NR1H3 Q13133 1/20 0.40
CYP2A13 Q16696 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL20912805 0.97 MAPT (0.58) MAPTTAAR1KMT2AMEN1ACHE
Bromide SCHEMBL20912804 0.97 MAPT (0.58) MAPTTAAR1KMT2AMEN1ACHE
SCHEMBL21509737 0.89 MAPT (0.51) MAPTTAAR1KMT2AMEN1TSHR
SCHEMBL9875884 0.89 MAPT (0.51) MAPTTAAR1KMT2AMEN1TSHR
SCHEMBL12677859 0.88 MAPT (0.70) MAPTTAAR1KMT2AMEN1ACHE
SCHEMBL17264228 0.87 MAPT (0.50) MAPTTAAR1KMT2AMEN1ACHE
SCHEMBL18297347 0.86 MAPT (0.68) MAPTTAAR1KMT2AMEN1ACHE
SCHEMBL20175903 0.84 MAPT (0.77) MAPTTAAR1KMT2AMEN1ACHE
SCHEMBL11526249 0.83 MAPT (0.50) MAPTTAAR1KMT2AMEN1ACHE
SCHEMBL2121111 0.83 MAPT (0.50) MAPTTAAR1KMT2AMEN1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174523-A1 SYNTHESIS OF ZEOLITIC MATERIAL HAVING AFT FRAMEWORK STRUCTURE AND SCR CATALYSTS COMPRISING THE SAME BASF CORPORATION 2024-05-30 US claimed
US-20230271843-A1 CHA-TYPE ZEOLITE AND METHOD FOR PRODUCING THE SAME TOSOH CORPORATION (JP) 2023-08-31 US claimed
US-11708277-B2 Low pressure synthesis of zeolite SSZ-13 CHEVRON U.S.A. INC. (US) 2023-07-25 US claimed
EP-4194403-A1 CHA-TYPE ZEOLITE AND METHOD FOR PRODUCING SAME Tosoh Corporation (JP) 2023-06-14 EP claimed
EP-4188879-A1 LOW PRESSURE SYNTHESIS OF ZEOLITE SSZ-13 Chevron U.S.A. Inc. (US) 2023-06-07 EP claimed
WO-2022029525-A1 LOW PRESSURE SYNTHESIS OF ZEOLITE SSZ-13 CHEVRON U.S.A. INC. (US) 2022-02-10 WO claimed
US-20220033271-A1 LOW PRESSURE SYNTHESIS OF ZEOLITE SSZ-13 CHEVRON U.S.A. INC. 2022-02-03 US claimed
US-20210053041-A1 PROCESS FOR PREPARING A ZEOLITIC MATERIAL COMPRISING TI AND HAVING FRAMEWORK TYPE CHA BASF SE (DE) 2021-02-25 US claimed
US-20200114340-A1 A COMPOSITION COMPRISING A ZEOLITIC MATERIAL SUPPORTED ON A SUPPORT MATERIAL BASF SE (DE) 2020-04-16 US claimed
EP-4736995-A1 SEPARATION MEMBRANE, SEPARATION MEMBRANE LAYERED BODY, SEPARATION MODULE OR SEPARATION TOWER, HYDROGEN RECOVERY SYSTEM, AND HYDROGEN SEPARATION AND RECOVERY METHOD Mitsubishi Chemical Corporation (JP) 2026-05-06 EP disclosed
US-20260115671-A1 SEPARATION MEMBRANE, SEPARATION MEMBRANE LAYERED BODY, SEPARATION MODULE OR SEPARATION TOWER, HYDROGEN RECOVERY SYSTEM, AND HYDROGEN SEPARATION AND RECOVERY METHOD MITSUBISHI CHEMICAL CORPORATION (JP) 2026-04-30 US disclosed
EP-4691613-A1 ZEOLITE MEMBRANE COMPOSITE AND METHOD FOR PRODUCING PURIFIED COMPONENT Mitsubishi Chemical Corporation (JP) 2026-02-11 EP disclosed
US-20260021454-A1 ZEOLITE MEMBRANE COMPOSITE AND METHOD FOR PRODUCING PURIFIED COMPONENT MITSUBISHI CHEMICAL CORPORATION (JP) 2026-01-22 US disclosed
WO-2025005285-A1 SEPARATION MEMBRANE, SEPARATION MEMBRANE LAYERED BODY, SEPARATION MODULE OR SEPARATION TOWER, HYDROGEN RECOVERY SYSTEM, AND HYDROGEN SEPARATION AND RECOVERY METHOD 三菱ケミカル株式会社 2025-01-02 WO disclosed
US-20110142755-A1 PROCESS FOR THE PREPARATION OF ZEOLITES HAVING B-CHA STRUCTURE BASF SE (DE) 2011-06-16 US disclosed
WO-2011064186-A1 PROCESS FOR THE PREPARATION OF ZEOLITES HAVING CHA STRUCTURE BASF SE (DE) 2011-06-03 WO disclosed
EP-2325143-A2 Process for the preparation of zeolites having B-CHA structure BASF SE (DE) 2011-05-25 EP disclosed
US-20110076229-A1 PROCESS FOR THE DIRECT SYNTHESIS OF Cu CONTAINING ZEOLITES HAVING CHA STRUCTURE BASF SE (DE) 2011-03-31 US disclosed
EP-2297036-A1 PROCESS FOR THE DIRECT SYNTHESIS OF CU CONTAINING ZEOLITES HAVING CHA STRUCTURE BASF SE (DE) 2011-03-23 EP disclosed
WO-2009141324-A1 PROCESS FOR THE DIRECT SYNTHESIS OF CU CONTAINING ZEOLITES HAVING CHA STRUCTURE BASF SE (DE) 2009-11-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021454-A1 ZEOLITE MEMBRANE COMPOSITE AND METHOD FOR PRODUCING PURIFIED COMPONENT PCTP, PICALM, VMA21 MAPT 3967/4885TAAR1 3192/4885KMT2A 4376/4885
US-20260115671-A1 SEPARATION MEMBRANE, SEPARATION MEMBRANE LAYERED BODY, SEPARATION MODULE OR SEPARATION TOWER, HYDROGEN RECOVERY SYSTEM, AND HYDROGEN SEPARATION AND RECOVERY METHOD APMAP, LETM1, STOML2 MAPT 4670/4885TAAR1 1285/4885KMT2A 2698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.